New Veeva Clinical Network Applications Connect Sponsors, Sites, and Patients to Accelerate Clinical Trials
Veeva Systems (NYSE: VEEV) today announced the first two applications built on the Veeva Clinical Network, the industry’s only solution that links sponsors, clinical research sites, and patients for paperless, patient-centric trials. Veeva Site Connect connects sponsors and clinical research sites to enable paperless information exchange throughout a trial. With Veeva eConsent, clinical researchers can digitize the consent process with patients and review boards, while delivering transparency to sponsors.
“Paper and manual processes are slowing trial execution and impacting the patient experience,” said Jim Reilly, vice president of Veeva Vault R&D. “By bringing together the growing community of research sites using Veeva SiteVault with the many sponsors leveraging the Veeva Vault Clinical Suite, we aim to accelerate the move to paperless and patient-centric clinical trials. Veeva Clinical Network will enable faster studies and make it easier for patients to participate in trials.”
Veeva Site Connect Now Available to Automate Information Sharing
Veeva Site Connect transforms information sharing between sites and sponsors from manual, paper-based transfers to an automated, digital exchange. By linking site operations on Veeva SiteVault to sponsor operations on Vault Clinical, key clinical trial processes are more efficient, including startup document exchange, safety letter distribution, site payment letters, and study closeout transfers. Automating information exchange improves site engagement and satisfaction, while allowing sites to focus more on patient care.
“Manually maintaining trial information and limited visibility into key study documents results in a lot of duplicate effort across sponsors and sites,” said Peter Sallstig, global head development division, senior vice president & corporate officer at Santen, a specialized company dedicated to ophthalmology with products now reaching patients in over 60 countries. “Veeva Site Connect enables us to automatically link content between Veeva Vault eTMF and Veeva SiteVault for real-time document management, more efficient collaboration, and better execution.”
Veeva Site Connect is available today, with early adopters including a top 20 pharmaceutical company, a top 10 medical device company, and a leading research hospital.
Veeva eConsent to Make Patient Participation Easier in Clinical Trials
Veeva eConsent is a free solution for sites and patients that transforms the current paper-based consent process into a digital creation, approval, and exchange process. Sites can use Veeva eConsent to tailor sponsor-provided consents to the requirements of their ethics boards. The approved consent is then delivered to a patient’s mobile device for their consent, while providing sponsors visibility throughout the process.
“The informed consent process in clinical trials has been historically paper-based and inefficient,” said Jill Janssen, director at Vanderbilt University Medical Center. “Veeva eConsent reduces complex and time-consuming paperwork to improve compliance and enhance the patient experience.”
Veeva eConsent is planned for availability in early 2021. Learn more about Veeva eConsent and Veeva Site Connect at the upcoming Veeva R&D and Quality Summit, 13-14 October, 2020. The online event is open to life sciences industry professionals. Register and stay up-to-date on program details at veeva.com/Summit.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud solutions—including data, software, and services—for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 900 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. The company is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Smiths Detection Inc. receives a $90.8M IDIQ contract to manufacture Joint Chemical Agent Detector Adapter for US Department of Defense22.10.2020 16:00:00 CEST | Press release
Smiths Detection Inc. (SDI), a global leader in threat detection and security screening technologies, announced it will initiate manufacturing of the Solid Liquid Adapter (SLA) following an indefinite delivery/indefinite quantity (IDIQ) award, worth potentially $90.8M over a maximum nine (9) year ordering period, with the US Department of Defense (DoD). The SLA adds new and expanded detection and identification capabilities to Joint Chemical Agent Detectors (JCAD), one of the DoD’s largest chemical detection programs in history. JCAD fitted with an SLA (JCAD SLA) gives the SLA operator the ability to both test for illicit drugs, including opioids such as fentanyl, and detect explosive compounds – without compromising the conventional chemical warfare agent detection capability of the JCAD. Speaking about the newly developed technology, Smiths Detection Inc. President, Shan Hood, said, “The SLA leverages existing technology, extending both capabilities and the life-cycle of widely deplo
Hilton Effect Foundation Reveals 2020 Grants and Achieves $1 Million in Global COVID-19 Community Response Efforts22.10.2020 16:00:00 CEST | Press release
The Hilton Effect Foundation announced today its 2020 Hilton Effect grantees, which include community-based organizations playing a direct role in COVID-19 pandemic recovery efforts. Through these grants and donations already made by the Foundation, which serves as Hilton’s primary philanthropic arm, the Foundation has now awarded more than $1 million dollars in COVID-19 community response efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201022005724/en/ Hilton Effect Foundation reveals 2020 grants and achieves $1 million in global COVID-19 community response efforts. (Graphic: Hilton Effect Foundation) “A core part of the Hilton Effect Foundation’s work is to support our communities around the world through both good times and bad,” said Kate Mikesell, president, Hilton Effect Foundation. “From the very start of the pandemic, we have been listening to community leaders about the direct and indirect challenges they ar
Andersen Global Adds Chancery Chambers to Caribbean Platform22.10.2020 15:30:00 CEST | Press release
Continuing to add breadth to the organization’s coverage in the eastern Caribbean region, Andersen Global enters into a Collaboration Agreement with legal firm Chancery Chambers in Barbados. Founded by Partner Sir Trevor Carmichael, Chancery Chambers is ranked Band 1 by Chambers and Partners and has substantial public and private sector experience at the national and international level. The firm’s full-service capabilities include national and international arbitration, corporate and commercial, employment law, banking and finance, aviation law, environmental law, intellectual property, insurance, M&A and real estate, specializing in tax advisory, corporate advisory and litigation. “We remain dedicated to being a benchmark organization for quality and best-in-class client solutions, and we believe the best way to accomplish this is by investing in our people and in our firm,” Sir Trevor said. “We are focused on the future and laying the groundwork for the next generation. Our collabor
Moody’s Retires Green Bond Assessment Product in Light of Market-Leading Second - Party Opinion Service Available from its Affiliate Vigeo Eiris22.10.2020 15:18:00 CEST | Press release
Moody’s announced today that it has retired its Green Bond Assessment (GBA) product in light of the market-leading Second-Party Opinion (SPO) Service for sustainable bonds provided by its affiliate Vigeo Eiris (VE). This move follows the recently announced formation of the Moody’s ESG Solutions Group and last year’s expansion of Moody’s ESG capabilities with investments in VE, a global pioneer in ESG assessments, data, tools and sustainable finance; and Four Twenty Seven, a leader in climate risk analysis. VE offers a range of leading sustainable finance solutions, including a recently-enhanced SPO service for green, social, sustainability, and transition bonds as well as issuer sustainability ratings that provide an in-depth and forward-looking evaluation on a company’s sustainability credentials. In view of VE’s market-leading SPO product, Moody’s Investors Service (MIS) has retired the GBA product and has withdrawn all outstanding GBAs today. “The sustainable bond market has been on
IAVI, Merck, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access22.10.2020 15:00:00 CEST | Press release
Today, IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges, and Serum Institute of India Pvt. Ltd., a leading manufacturer of vaccines and biologics, announced an agreement with Merck, a leading science and technology company, to develop SARS-CoV-2 neutralizing monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovative interventions to address the COVID-19 pandemic. The agreement builds on the advanced antibody discovery and optimization expertise of IAVI and Scripps Research, gained from years of experience in HIV broadly neutralizing antibody research and development, and on Merck’s and Serum Institute’s significant capabilities in design and scale up of accelerated manufacturing processes for mAb production. The global development plan is being led by the three organizations in partnership. The two companies have broad networks across complementary geographic areas that will be crucial to reach gi
MANSCAPED™ Goes Global, Offering Below-The-Waist Grooming Products to 1 Billion Consumers Worldwide22.10.2020 15:00:00 CEST | Press release
Male grooming. In this day and age, these two words can - and should - mean trimming and tidying up all areas of a man’s body, including the nether regions. You may have thought about it, or even partaken in this all-important activity and reaped the results! But was it as enjoyable as it was effective? And, more importantly, were you equipped with the right tools for the job? This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201022005418/en/ The leader in male below-the-waist grooming is now shipping its sought-after collection of precision engineered tools, unique formulations, and accessories to the European Union. (Photo: Business Wire) If you are not already familiar with the pioneer below-the-waist grooming and hygiene brand, let us formally introduce you to MANSCAPED™. This California-based startup has single-handedly disrupted the men’s grooming industry and created a completely new category in the consumer packaged goo